Bentham Science Publishers is pleased to announce that MicroRNA has been awarded an Impact Factor ranking by Clarivate Analytics. The journal, currently edited by Dr. Alberto Izzoti (University of Genoa), has been providing readers with cutting-edge research on molecular biology and the therapeutic applications of MicroRNAs. Bentham Science extends its heartfelt congratulations to all journal contributors, including editors, authors and staff who have supported the journal since its inception.
Impact Factor Update: With MicroRNA ’s addition to the Impact Factor list, 62 Bentham Science journals now hold this prestigious distinction. Current Neuropharmacology continues to lead the list with a 2024 impact factor of 5.3, followed by Recent Patents on Anti-Cancer Drug Discovery (4.1) and Current Medicinal Chemistry (3.5). Bentham Science is committed to publishing impactful research in the years to come.
About Bentham Science Publishers: Bentham Science Publishers is a leading academic publisher that specializes in medical and general STM (Science, Technology, and Medicine) disciplines. With a diverse portfolio of over 130 hybrid and Open Access journals, Bentham Science is dedicated to disseminating high-quality research to the global scientific community. Founded in 1992, Bentham Science was established "by scientists for scientists" and has maintained an unwavering commitment to excellence. Its peer review process is among the most rigorous in the industry, with all manuscripts undergoing double blind review by a verified pool of experts.
For media inquiries, please contact: marketing@benthamscience.net
Bentham Science Publishers sincerely thanks all those who have contributed to its mission of advancing scientific knowledge while upholding the highest standards of integrity and scholarly excellence.
Updated list of Bentham Science Journals with Impact Factors:
#
Journals
IF 2024
1
5.3
2
Recent Patents on Anti-Cancer Drug Discovery
4.1
3
3.5
4
5
3.3
6
Mini-Review In Medicinal Chemistry
7
Current Topics In Medicinal Chemistry
8
Recent Patent on Nanotechnology
3.1
9
10
CNS & Neurological Disorders - Drug Targets
11
Anti-Cancer Agents in Medicinal Chemistry
12
2.9
13
2.8
14
Current Pharmaceutical Biotechnology
2.6
15
Medicinal Chemistry
16
2.5
17
18
19
Mini-Reviews In Organic Chemistry
2.3
20
Current Stem Cell Research & Therapy
2.2
21
22
Current Vascular Pharmacology
2.1
23
24
Current Protein & Peptide Science
25
Endocrine Metabolic & Immune Disorders - Drug Targets
26
1.9
27
28
1.8
29
1.7
30
Current Neurovascular Research
31
Combinatorial Chemistry & High Throughput Screening
32
33
34
Current Computer-Aided Drug Design
1.6
35
36
1.5
37
1.4
38
1.3
39
1.2
40
1.1
41
42
Current Nutrition & Food Science
43
Recent Advances in Inflammation & Allergy Drug Discovery
44
45
Letters In Organic Chemistry
46
47
Reviews On Recent Clinical Trials
48
Current Cancer Therapy Reviews
0.9
49
Current Reviews In Clinical And Experimental Pharmacology
50
51
52
0.8
53
0.7
54
55
56
0.6
57
Recent Advances In Electrical & Electronic Engineering
0.5
58
Current Psychiatry Research And Reviews
0.4
59
Open Cardiovascular Medicine Journal
60
Current Respiratory Medicine Reviews
0.3
61
Current Women's Health Reviews
62